Resolution of racemic anti-hepatitis drug ( +/- ) -bicyclol / 药学学报
Acta Pharmaceutica Sinica
;
(12): 221-224, 2006.
Artigo
em Chinês
| WPRIM
| ID: wpr-271472
ABSTRACT
<p><b>AIM</b>To study the different biological activities of the enantiomers of the anti-hepatitis drug (+/-)-bicyclol, the (+/-)-bicyclol was resolved.</p><p><b>METHODS</b>By being treated with optically active alkaloid, the two diastereoisomers alkaloid salts of the compound could be obtained, separately. After decomposing and methylating, they were transformed separately into (-)-bicyclol and (+)-bicyclol.</p><p><b>RESULTS</b>The two enantiomers of bicyclol were determined by melting point, [alpha]D, 1H NMR, MS and chiral column HPLC.</p><p><b>CONCLUSION</b>Comparison of hepatoprotective action of racemic bicyclol and (-)-, (+)-bicyclol on experimental liver injury, the effect of (-)-bicyclol was two times more potent than that of racemic bicyclol and the potency of (+)-bicyclol was much less than that of the racemate.</p>
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Rotação Ocular
/
Farmacologia
/
Aspartato Aminotransferases
/
Estereoisomerismo
/
Compostos de Bifenilo
/
Sangue
/
Intoxicação por Tetracloreto de Carbono
/
Estrutura Molecular
/
Química
/
Alanina Transaminase
Limite:
Animais
Idioma:
Chinês
Revista:
Acta Pharmaceutica Sinica
Ano de publicação:
2006
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS